$ISR NEWS IS OUT: IsoRay, Inc. (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological cancers, today announced the Company’s participation at the upcoming American Urological Association (AUA) Annual Meeting, taking place on May 18-21, 2018 in San Francisco, CA. https://finance.yahoo.com/news/isoray-announces-participation-american-urological-123000772.html
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.